dc.contributor.author | Melidou, Angeliki | |
dc.contributor.author | Pereyaslov, Dmitriy | |
dc.contributor.author | Hungnes, Olav | |
dc.contributor.author | Prosenc, Katarina | |
dc.contributor.author | Alm, Erik | |
dc.contributor.author | Adlhoch, Cornelia | |
dc.contributor.author | Fielding, James | |
dc.contributor.author | Sneiderman, Miriam | |
dc.contributor.author | Martinuka, Oksana | |
dc.contributor.author | Celentano, Lucia Pastore | |
dc.contributor.author | Pebody, Richard | |
dc.contributor.author | WHO European Region influenza surveillance network | |
dc.contributor.author | Pozo Sanchez, Francisco | |
dc.contributor.author | Casas Flecha, Inmaculada | |
dc.date.accessioned | 2022-09-02T10:08:44Z | |
dc.date.available | 2022-09-02T10:08:44Z | |
dc.date.issued | 2020-11 | |
dc.identifier.citation | Euro Surveill. 2020 Nov;25(46):2001822. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/14935 | |
dc.description.abstract | The COVID-19 pandemic negatively impacted the 2019/20 WHO European Region influenza surveillance. Compared with previous 4-year averages, antigenic and genetic characterisations decreased by 17% (3,140 vs 2,601) and 24% (4,474 vs 3,403). Of subtyped influenza A viruses, 56% (26,477/47,357) were A(H1)pdm09, 44% (20,880/47,357) A(H3). Of characterised B viruses, 98% (4,585/4,679) were B/Victoria. Considerable numbers of viruses antigenically differed from northern hemisphere vaccine components. In 2020/21, maintaining influenza virological surveillance, while supporting SARS-CoV-2 surveillance is crucial. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | European Centre for Disease Prevention and Control (ECDC) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | COVID-19 | es_ES |
dc.subject | Europe | es_ES |
dc.subject | SARS-CoV-2 | es_ES |
dc.subject | Influenza virus | es_ES |
dc.subject | Pandemic | es_ES |
dc.subject | Surveillance | es_ES |
dc.subject | Virus characterization | es_ES |
dc.subject.mesh | Epidemiological Monitoring | es_ES |
dc.subject.mesh | Antigens, Viral | es_ES |
dc.subject.mesh | Betacoronavirus | es_ES |
dc.subject.mesh | COVID-19 | es_ES |
dc.subject.mesh | Coronavirus Infections | es_ES |
dc.subject.mesh | Disease Notification | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Influenza A Virus, H1N1 Subtype | es_ES |
dc.subject.mesh | Influenza A Virus, H3N2 Subtype | es_ES |
dc.subject.mesh | Influenza A virus | es_ES |
dc.subject.mesh | Influenza B virus | es_ES |
dc.subject.mesh | Influenza, Human | es_ES |
dc.subject.mesh | Pandemics | es_ES |
dc.subject.mesh | Pneumonia, Viral | es_ES |
dc.subject.mesh | Population Surveillance | es_ES |
dc.subject.mesh | RNA, Viral | es_ES |
dc.subject.mesh | SARS-CoV-2 | es_ES |
dc.subject.mesh | Sequence Analysis, DNA | es_ES |
dc.title | Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 33213683 | es_ES |
dc.format.volume | 25 | es_ES |
dc.format.number | 46 | es_ES |
dc.format.page | 2001822 | es_ES |
dc.identifier.doi | 10.2807/1560-7917.ES.2020.25.46.2001822 | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1560-7917 | es_ES |
dc.relation.publisherversion | https://doi.org/10.2807/1560-7917.ES.2020.25.46.2001822 | es_ES |
dc.identifier.journal | Euro Surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |